Cleviprex
Active substance: clevidipine
EMULSION · CLEVIDIPINE .5 mg/mL
United StatesActive
Marketing holder: Fresenius Kabi Austria GmbH
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CLEVIDIPINE · .5 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12091-7136-7a18-a92e-6f5c9fe07324,01a12093-3d73-7143-b272-c23879908cee,01a12097-db29-70ba-a07a-c67ca48017b1;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 18124-011
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 18124-011 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 18124-011 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 18124-011 · Verified 2026-10-09 · open in source